Using 23andMe to Reunite Families at the Border Comes With Serious Privacy Risks
By Tonya Riley,
Mother Jones [Cites CGS' Marcy Darnovsky]
| 06. 22. 2018
On Wednesday, President Donald Trump announced an end to administration’s policy of separating families at the border. But the administration hasn’t figured out how to reunite the parents and children that have already been split apart. A day after Trump’s announcement, Rep. Jackie Speier (D-Calif.) suggested a novel idea: recruit 23andMe, the DNA-testing company, to help separated families find missing relatives. The company itself quickly volunteered its services for the cause. But legal and genetic experts say that the solution might cause more harm than good.
Speier told Buzzfeed News on Thursday that she spoke with executives at 23andMe, which is headquartered in the congresswoman’s district, about providing testing assistance to reunite families at the border. By Thursday evening, 23andMe CEO Anne Wojcicki said that the company “would welcome any opportunity to help” and was “waiting to see the best way to follow up and make it happen.” (23andMe donated $5,000 to Speier’s 2016 campaign.)
“I implore the President, Attorney General Sessions, and HHS Secretary Azar to accept this generous and altruistic offer, particularly in light of the fact that...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...